Avid Bioservices

Orange, United States Founded: 2002 • Age: 24 yrs Acquired By GHO Capital Partners
Drug substance development, analytical, and compliance services are provided.
Annual revenue $139.9M Latest available
Total funding - 2 rounds
Employees 501 Tracked headcount
Investors 3 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Avid Bioservices

Avid Bioservices is a company based in Orange (United States) founded in 2002 by Edward Legere was acquired by GHO Capital Partners in November 2024. The company has 501 employees as of December 31, 2022. Avid Bioservices offers products and services including Mammalian Protein Services and Viral Vector Services. Avid Bioservices operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, ProBioGen AG and Polpharma Biologics, among others.

  • Headquarter Orange, United States
  • Employees 501 as on 31 Dec, 2022
  • Founders Edward Legere
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Avid Bioservices, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $139.91 M (USD)
    12
    as on Apr 30, 2024
  • Net Profit
    $259 K (USD)
    -100
    as on Apr 30, 2023
  • EBITDA
    -$18.68 M (USD)
    -619
    as on Apr 30, 2024
  • Latest Funding Round
    $1.07 M (USD), Grant

    Sep 11, 2009

  • Investors
    HHS

    & 2 more

  • Employee Count
    501

    as on Dec 31, 2022

  • Acquired by
    GHO Capital Partners

    (Nov 07, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Avid Bioservices

Avid Bioservices offers a comprehensive portfolio of products and services, including Mammalian Protein Services and Viral Vector Services.

Product name locked
Category locked
Primary

Development and manufacturing of mammalian proteins for pharmaceuticals.

Product name locked
Category locked
Locked

Development and manufacturing of viral vectors for gene therapy.

People of Avid Bioservices

Headcount 200-500
Employee Profiles 85
Board Members and Advisors 3
Employee Profiles
People
Elie Hanania
VP, Process Development, Viral Vector Technologies
People
Richard Richieri
COO
People
Pramthesh Patel
VP Process Development
People
Michael Alston, Jr.
VP, Operations

Unlock access to complete

Board Members and Advisors
people
Jeanne A. Thoma
Director

Unlock access to complete

Funding Insights of Avid Bioservices

Investors in Avid Bioservices

Avid Bioservices has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, GHO Capital and Ampersand Capital Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Specialist healthcare investment advisory services are provided by GHO Capital.
Locked Locked Locked
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for Avid Bioservices

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Avid Bioservices

Investments
Premium access

Investment portfolio details for Avid Bioservices

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Avid Bioservices

Premium access

Detailed financials for Avid Bioservices

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Avid Bioservices Comparisons

Avid Bioservices Primary company
Description
Drug substance development, analytical, and compliance servi...
Location
Orange, United States
Founded Year
2002
Annual Revenue
$139.91 M (USD)
Net Profit
$259 K (USD)
EBITDA
-$18.68 M (USD)
Employees
501
As of 2022
Premium access

Peer comparison for Avid Bioservices

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Avid Bioservices

Avid Bioservices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, ProBioGen AG and Polpharma Biologics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Mammalian cell culture biologics are developed through contract research services.
Locked Locked Locked
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
Locked Locked Locked
Contract manufacturing solutions for biologics are provided to Asian companies.
Locked Locked Locked
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
Locked Locked Locked
Develops and manufactures biosimilar drugs and CDMO services for biotechnology applications.
Premium access

Detailed competitors of Avid Bioservices

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Avid Bioservices

Premium access

Complete news archive for Avid Bioservices

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avid Bioservices

Avid Bioservices was founded in 2002 and raised its 1st funding round 7 years after it was founded.

Avid Bioservices is headquartered in Orange, United States. It is registered at Orange, California, United States.

Nicholas Green is the current CEO of Avid Bioservices.

As of Dec 31, 2022, the latest employee count at Avid Bioservices is 501.

Annual revenue of Avid Bioservices is $139.91M as on Apr 30, 2024.

Avid Bioservices was established in 2002 in Orange, United States, operating as a contract development and manufacturing organization within the biopharmaceutical industry. CGMP manufacturing capabilities are utilized for drug substances, alongside analytical testing, stability assessments, and process validation support. Quality assurance and regulatory compliance services are also delivered, including inspection readiness, to support client operations in the sector.

Avid Bioservices's top competitors include Bionova Scientific, Rentschler Biopharma and Just Biotherapeutics.

Avid Bioservices offers Mammalian Protein Services and Viral Vector Services.

Avid Bioservices has 3 investors. Key investors include HHS, GHO Capital, and Ampersand Capital Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available